Add BrightSurf on Google Email

Mass General Brigham–developed cholera vaccine completes phase 1 trial

A single-dose oral cholera vaccine called PanChol has completed a phase 1 clinical trial with positive results, offering hope for combating the devastating disease globally. The vaccine was developed by Mass General Brigham and shows promise in preventing severe vomiting and diarrhea caused by Vibrio cholerae bacteria.

SourceBrigham and Women's Hospital·JournalThe Lancet Infectious Diseases·TypeRandomized controlled/clinical trial·DateJan 7, 2026

Baveno VII guidelines: shaping the future of portal hypertension management

The Baveno VII consensus guidelines have reshaped portal hypertension management, focusing on early intervention and noninvasive diagnostics. Nonselective beta-blockers and transjugular intrahepatic portosystemic shunt (TIPS) are recommended for clinically significant portal hypertension diagnosis.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeSystematic review·DateDec 19, 2025

What prevents more cancer patients from enrolling in potentially life-saving clinical trials?

A new study by Case Western Reserve University and University Hospitals found that financial factors are the strongest predictors of participation in cancer research studies. The researchers recommend addressing practical challenges like transportation, childcare, and lost wages to make clinical trials more inclusive.

SourceCase Western Reserve University·JournalJournal of the National Comprehensive Cancer Network·TypeData/statistical analysis·DateDec 18, 2025

Blood test may help identify which colon cancer patients benefit from NSAIDs

A blood test may help doctors identify which patients with colon cancer can benefit from anti-inflammatory medication and chemotherapy after surgery. The test measures circulating tumor DNA levels, and high-risk patients who test positive see improved survival rates when taking celecoxib with chemotherapy.

SourceAlliance for Clinical Trials in Oncology·JournalJAMA Oncology·TypeRandomized controlled/clinical trial·DateDec 15, 2025

Rangsit University study shows simple bypass protocol improves outcomes in chronic cerebral occlusion

A study from Rangsit University shows that a simple bypass protocol guided by mean transit time can improve symptoms in 80% of patients with chronic cerebral occlusion or moyamoya disease. The protocol uses non-stress testing to evaluate cerebrovascular reserve and predict postoperative improvement.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeObservational study·DateDec 12, 2025

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A new study presented at ASH 2025 suggests that a virtual program focusing on diet and exercise can help reduce the severity of side effects associated with lymphoma treatment. The program, LIFE-L, showed significant improvements in symptoms such as anxiety, depression, pain, fatigue, and constipation among participants.

Conquer the diseases of aging and humans could live far longer than we think, scientists propose

Researchers argue that widely used proxies for aging may conflate genuine modifications with simpler effects on physiology. Targeting specific pathologies can extend lifespan without slowing aging process. Historically, increased human lifespan was primarily driven by reduced infectious disease mortality, not a fundamental slowing of a...

SourceGenomic Press·JournalGenomic Psychiatry·TypeLiterature review·DateDec 2, 2025

New research confirms HPV vaccination prevents cervical cancer

Two new Cochrane reviews show that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus. Girls vaccinated before the age of 16 were found to be 80% less likely to develop cervical cancer.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateNov 23, 2025

Root canal treatment reduces heart disease and diabetes risk

A study published in Journal of Translational Medicine found that successful root canal treatment can reduce inflammation linked to heart disease and improve levels of blood sugar and cholesterol. The researchers discovered a link between monitoring blood metabolic markers after dental treatment, which could help assess recovery and risk.

SourceKing's College London·JournalJournal of Translational Medicine·DateNov 17, 2025

Do all countries benefit from clinical trials? A new Yale study examines the data

A new Yale study found that only 24% of medicines tested in clinical trials received market authorization, highlighting a significant 'test it but don't sell it' problem. The study highlights the need for collective effort from pharma companies, countries, and other stakeholders to improve post-trial access to life-saving medicines.

SourceYale University·JournalJAMA Internal Medicine·TypeData/statistical analysis·DateNov 17, 2025

Clinical trial in Africa finds single-dose malaria treatment combining four existing drugs as effective as more onerous multi-day, multi-dose regimen

A clinical trial in Africa has discovered a single-dose treatment combining sulfadoxine, pyrimethamine, artesunate, and pyronaridine (SPAP) that is as effective as traditional multi-day treatments in curing uncomplicated malaria. The study addresses the growing threat of drug-resistant malaria parasites and improves treatment adherence.

Chinese Neurosurgical Journal study compares carotid plaque composition in patients from China and US

Researchers analyzed carotid plaque samples from 75 Chinese and 111 US patients, revealing distinct differences in plaque morphology, size, and composition. The study highlights the importance of understanding population-specific variations to develop personalized treatment approaches for cerebrovascular events.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeImaging analysis·DateNov 11, 2025

How to identify and prevent fraudulent participants in health research

Researchers can utilize a combination of automated and manual actions to quickly identify suspicious behavior and prevent fraudulent actors from enrolling in online studies. A comprehensive checklist of indicators helps researchers spot potential fraud, such as similar patterns in email addresses or predictable responses.

SourceBoston University School of Public Health·JournalJournal of Medical Internet Research·TypeCase study·DateNov 5, 2025

Reducing reliance on corticosteroids with rituximab: renewed hope for adult-onset patients with relapsing nephrotic syndrome

A randomized clinical trial has shown that rituximab is effective in preventing relapses and reducing the need for corticosteroids in adults with relapsing nephrotic syndrome. The study involved 66 adult patients treated with either rituximab or a placebo, with impressive results at the 49-week follow-up.

SourceThe University of Osaka·JournalJAMA·TypeRandomized controlled/clinical trial·DateNov 5, 2025

Louisiana Environmental influences on Child Health Outcomes, ECHO, Collaboration secures federal funding renewal

The Louisiana ECHO program, which focuses on pre-, peri- and postnatal outcomes, obesity, and other areas, will continue its efforts to expand access to clinical trials for Louisiana children. The grant renewal supports the collaboration between researchers from Pennington Biomedical and Ochsner Health System, as well as two free-stand...

Targeted immunotherapy combination offers hope to older adults with leukemia

Researchers found a targeted immunotherapy regimen yielded promising survival outcomes for patients with B-cell ALL, outperforming historical results. The treatment was well-tolerated, with more than half completing the full course of therapy, and responded similarly in patients with complex medical histories.

SourceAlliance for Clinical Trials in Oncology·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateOct 20, 2025

Missing molecule may explain Down syndrome

Scientists found a promising candidate, pleiotrophin, which is essential for brain development and function; restoring it may improve brain circuits in individuals with Down syndrome and other neurological diseases. The study's findings suggest using modified viruses to deliver the protein directly into cells could lead to new treatments.

SourceUniversity of Virginia Health System·JournalCell Reports·DateOct 17, 2025

Discrimination experiences among medical students

A cross-sectional study reveals that medical students with disabilities experience both general and race-based discrimination, as well as gender-based discrimination. The findings highlight the need to address these intersecting forms of discrimination in medical education.

SourceJAMA Network·JournalJAMA Network Open·DateOct 16, 2025

Boston Children’s receives a $35 million donation to accelerate development of therapeutic options for children with brain disorders through the Rosamund Stone Zander and Hansjoerg Wyss Translational Neuroscience Center

Boston Children's Hospital has received a $35 million donation from Hansjoerg Wyss to further its translational neuroscience research, focusing on rare brain disorders and intellectual disability. The gift will support clinical trials, fellowships, and pilot studies, aiming to develop new therapies for vulnerable children.

Can digital health tools help younger cancer survivors better predict future health risks?

A groundbreaking study enrolls 465 AYA cancer patients to test if chatbot technology and digital education tools increase uptake of genetic counseling and improve patient outcomes. The trial aims to address longstanding gaps in genetic services for AYAs aged 18-39, who often receive care with limited access to genetic specialists.

SourceAlliance for Clinical Trials in Oncology·TypeRandomized controlled/clinical trial·DateSep 30, 2025